Latest & greatest articles for nortriptyline

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on nortriptyline or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on nortriptyline and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for nortriptyline

1. Nortriptyline

Nortriptyline Top results for nortriptyline - Trip Database or use your Google+ account Find evidence fast My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for nortriptyline The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

2. Nortriptyline for neuropathic pain in adults.

Nortriptyline for neuropathic pain in adults. BACKGROUND: Antidepressants are widely used to treat chronic neuropathic pain (pain due to nerve damage), usually in doses below those at which they exert antidepressant effects. An earlier review that included all antidepressants for neuropathic pain is being replaced by new reviews of individual drugs examining individual neuropathic pain conditions.Nortriptyline is a tricyclic antidepressant that is occasionally used for treating neuropathic pain (...) , and is recommended in European, UK, and USA guidelines. OBJECTIVES: To assess the analgesic efficacy and associated adverse events of nortriptyline for chronic neuropathic pain in adults. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and EMBASE from inception to 7 January 2015, and the reference lists of retrieved papers and other reviews. We also searched two clinical trials databases for ongoing or unpublished studies. SELECTION CRITERIA: We included

Cochrane2015

3. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial.

Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial. IMPORTANCE: Gastroparesis remains a challenging syndrome to manage, with few effective treatments and a lack of rigorously controlled trials. Tricyclic antidepressants are often used to treat refractory symptoms of nausea, vomiting, and abdominal pain. Evidence from well-designed studies for this use is lacking. OBJECTIVE: To determine whether treatment with nortriptyline results in symptomatic (...) improvement in patients with idiopathic gastroparesis. DESIGN, SETTING, AND PARTICIPANTS: The NORIG (Nortriptyline for Idiopathic Gastroparesis) trial, a 15-week multicenter, parallel-group, placebo-controlled, double-masked, randomized clinical trial from the National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium (GpCRC), comparing nortriptyline with placebo for symptomatic relief in idiopathic gastroparesis. One hundred thirty patients with idiopathic

JAMA2013 Full Text: Link to full Text with Trip Pro

4. Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis

Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis Dhippayom T, Chaiyakunapruk N, Jongchansittho T CRD summary The authors concluded that nortriptyline at doses between 75mg and 100mg (...) was not significantly associated with serious adverse events for patients without underlying cardiovascular disease. This was a well-conducted review, but given the variability across studies and small number of studies for the main outcomes these findings should be interpreted with caution. Authors' objectives To examine the safety of nortriptyline at doses equivalent to those used in aiding smoking cessation. Searching MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, CINAHL, PsycINFO, WHOLIS

DARE.2011

5. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression 19252156 2009 03 02 2009 06 02 2016 11 22 1472-1465 194 3 2009 Mar The British journal of psychiatry : the journal of mental science Br J Psychiatry Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. 252-9 10.1192/bjp.bp.108.057554 Tricyclic antidepressants and serotonin reuptake inhibitors are considered to be equally effective, but differences may have been (...) obscured by internally inconsistent measurement scales and inefficient statistical analyses. To test the hypothesis that escitalopram and nortriptyline differ in their effects on observed mood, cognitive and neurovegetative symptoms of depression. In a multicentre part-randomised open-label design (the Genome Based Therapeutic Drugs for Depression (GENDEP) study) 811 adults with moderate to severe unipolar depression were allocated to flexible dosage escitalopram or nortriptyline for 12 weeks

EvidenceUpdates2009

6. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. 19796802 2009 10 12 2009 10 29 2015 06 16 1474-547X 374 9697 2009 Oct 10 Lancet (London, England) Lancet Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. 1252-61 10.1016/S0140-6736(09)61081-3 Drugs for neuropathic pain have incomplete efficacy and dose-limiting side-effects when (...) given as monotherapy. We assessed the efficacy and tolerability of combined nortriptyline and gabapentin compared with each drug given alone. In this double-blind, double-dummy, crossover trial, patients with diabetic polyneuropathy or postherpetic neuralgia, and who had a daily pain score of at least 4 (scale 0-10), were enrolled and treated at one study site in Canada between Nov 5, 2004, and Dec 13, 2007. 56 patients were randomised in a 1:1:1 ratio with a balanced Latin square design to receive

Lancet2009

7. No difference in depression relapse rates between maintenance electroconvulsive therapy and lithium plus nortriptyline

No difference in depression relapse rates between maintenance electroconvulsive therapy and lithium plus nortriptyline No difference in depression relapse rates between maintenance electroconvulsive therapy and lithium plus nortriptyline | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here No difference in depression relapse rates between maintenance electroconvulsive therapy and lithium plus nortriptyline Article Text Therapeutics No difference in depression relapse rates between maintenance electroconvulsive therapy and lithium plus nortriptyline

Evidence-Based Mental Health2008

8. Mirtazapine and nortriptyline similarly effective third-line treatments for depression

Mirtazapine and nortriptyline similarly effective third-line treatments for depression Mirtazapine and nortriptyline similarly effective third-line treatments for depression | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword (...) Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Mirtazapine and nortriptyline similarly effective third-line treatments for depression Article Text Therapeutics Mirtazapine and nortriptyline similarly effective third-line treatments for depression Statistics from Altmetric.com No Altmetric data available for this article. Request permissions If you wish to reuse any or all

Evidence-Based Mental Health2008

9. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands Hoogendoorn M, Welsing P, Rutten-van Molken M P Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the long-term cost-effectiveness of varenicline to support smoking cessation in comparison with no treatment, bupropion, nortriptyline, or nicotine-replacement therapy (NRT). The authors concluded that varenicline was cost-effective compared

NHS Economic Evaluation Database.2008

10. Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial.

Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. 18441375 2008 05 30 2008 06 11 2016 10 19 1756-1833 336 7655 2008 May 31 BMJ (Clinical research ed.) BMJ Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. 1223-7 10.1136/bmj.39545.852616.BE To test the efficacy of nortriptyline plus nicotine (...) replacement therapy compared with placebo plus nicotine replacement therapy for smoking cessation. Pragmatic randomised controlled trial. National Health Service stop smoking service clinics. 901 people trying to stop smoking. Participants chose their nicotine replacement product, including combinations of nicotine replacement therapy, and received behavioural support. Nortriptyline was started one to two weeks before quit day, with the dose increased from 25 mg to 75 mg daily for eight weeks and reduced if not tolerated

BMJ2008 Full Text: Link to full Text with Trip Pro

11. Review: bupropion and nortriptyline each increase smoking cessation rates

Review: bupropion and nortriptyline each increase smoking cessation rates Review: bupropion and nortriptyline each increase smoking cessation rates | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: bupropion and nortriptyline each increase smoking cessation rates Article Text Therapeutics Review: bupropion and nortriptyline each increase smoking cessation rates Free Allan V Prochazka , MD, MSc Statistics from Altmetric.com No Altmetric data available for this article. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation

Evidence-Based Medicine (Requires free registration)2006

12. Should nortriptyline be used as a first-line aid to help smokers quit: results from a systematic review and meta-analysis

Should nortriptyline be used as a first-line aid to help smokers quit: results from a systematic review and meta-analysis Should nortriptyline be used as a first-line aid to help smokers quit: results from a systematic review and meta-analysis Should nortriptyline be used as a first-line aid to help smokers quit: results from a systematic review and meta-analysis Wagena E J, Knipschild P, Zeegers M P CRD summary This review assessed the efficacy of nortriptyline for smoking cessation (...) in motivated individuals who received a behavioural intervention. The authors concluded that nortriptyline increases rates of prolonged abstinence compared with placebo, and is safe and well tolerated. Apart from potential bias in the study selection process, this review was well conducted and the authors' conclusions are likely to be reliable in the short term. Authors' objectives To assess the efficacy of nortriptyline for smoking cessation in comparison with placebo and bupropion sustained-release

DARE.2005

13. Review: nortriptyline and bupropion each increase smoking cessation rates

Review: nortriptyline and bupropion each increase smoking cessation rates Review: nortriptyline and bupropion each increase smoking cessation rates | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: nortriptyline and bupropion each increase smoking cessation rates Article Text Therapeutics Review: nortriptyline and bupropion each increase smoking cessation rates Free Charles J Bentz , MD, FACP Statistics from Altmetric.com No Altmetric data available for this article. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation

Evidence-Based Medicine (Requires free registration)2005

14. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. 9892449 1999 01 21 1999 01 21 2016 10 17 0098-7484 281 1 1999 Jan 06 JAMA JAMA Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. 39-45 Elderly patients with major depression are at high risk for recurrence, increased (...) mortality, and chronic disability. To determine the efficacy of maintenance nortriptyline hydrochloride and interpersonal psychotherapy (IPT) in preventing recurrence of major depressive episodes in patients older than 59 years. A 2 x 2 randomized, double-blind, placebo-controlled clinical trial, stratified by therapist. University-based psychiatric research clinic. Of a total of 187 patients with recurrent nonpsychotic unipolar major depression (average age, 67 years; one third aged > or =70 years

JAMA1999

15. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. 9450712 1998 02 05 1998 02 05 2016 10 17 0098-7484 279 4 1998 Jan 28 JAMA JAMA Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. 287-91 Depression and ischemic heart disease often are comorbid conditions and, in patients who have had a myocardial infarction, the presence of depression is associated with increased mortality. Patients with heart disease need (...) a safe and effective treatment for depression. To compare the efficacy, cardiovascular effects, and safety of a specific serotonin reuptake inhibitor, paroxetine, with a tricyclic antidepressant, nortriptyline hydrochloride, in depressed patients with ischemic heart disease. Two-week placebo lead-in followed by a double-blind randomized 6-week medication trial. Research clinics in 4 university centers. Eighty-one outpatients meeting Diagnostic and Statistical Manual of Mental Disorders, Fourth

JAMA1998

16. Nortriptyline treatment of post-stroke depression: a double-blind study.

Nortriptyline treatment of post-stroke depression: a double-blind study. 6141377 1984 03 16 1984 03 16 2016 11 23 0140-6736 1 8372 1984 Feb 11 Lancet (London, England) Lancet Nortriptyline treatment of post-stroke depression: a double-blind study. 297-300 The efficacy of nortriptyline in the treatment of post-stroke depression was assessed by a double-blind study in thirty-four patients. Half of the patients had major depression. There was a significantly greater improvement in depression (...) in patients treated with nortriptyline than in a similar group of placebo-treated patients. Depression was measured by the Hamilton depression scale, Zung depression scale, present state examination, and an overall depression scale. Successfully treated patients had serum nortriptyline levels in the therapeutic range. Post-stroke depressions are common, severe, and longstanding, and the demonstrated efficacy of nortriptyline provides an important addition to the treatments available for stroke patients

Lancet1984

17. Effect of activated charcoal on absorption of nortriptyline.

Effect of activated charcoal on absorption of nortriptyline. 73903 1978 02 18 1978 02 18 2015 06 16 0140-6736 2 8050 1977 Dec 10 Lancet (London, England) Lancet Effect of activated charcoal on absorption of nortriptyline. 1203-5 The ability of 'Medicoal', a new effervescent, activated charcoal preparation, to adsorb nortriptyline, has been investigated both in vitro and in vivo. A single dose of the effervescent charcoal 30 min after a dose of 75 mg nortriptyline produced a 60% mean reduction (...) in both peak plasma levels and nortriptyline availability in healthy volunteers. Multiple doses of the effervescent charcoal produced 70% mean reduction in peak nortriptyline levels and availabiltiy. Activated charcoal is recommended for the treatment of tricyclic antidepressant poisoning. In in-vitro tests, a 10 g packet of the effervescent preparation containing 5 g activated charcoal) had an adsorptive capacity of approximately 3000 mg nortriptyline, a dose not usually exceeded in most cases

Lancet1977